Discussing Prognosis, Preferences, and End-of-Life Care in Advanced Cancer: We Need to Speak.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Patient Understanding of Multiple Myeloma and Communication Experiences (PUMMaCE): Results From a UK Survey.EJHaem · 2026
   Article
2. Delivering improved survivorship care for people affected by advanced or metastatic cancer.Acta oncologica (Stockholm, Sweden) · 2024
   Article
3. Knowledge and attitudes about end-of-life decisions, good death and principles of medical ethics among doctors in tertiary care hospitals in Sri Lanka: a cross-sectional study.BMC medical ethics · 2021
   Article
4. Association Between Delivery System Structure and Intensity of End-of-Life Cancer Care.JCO oncology practice · 2020
   Article

Corrections and comments

• Comment on
  Evaluating an Intervention to Improve Communication Between Oncology Clinicians and Patients With Life-Limiting Cancer: A Cluster Randomized Clinical Trial of the Serious Illness Care Program.2019

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as